Peritoneal dialysis (PD) is a treatment for patients with severe chronic kidney disease. This type of dialysis uses the patient'speritoneum in the abdomen as a membrane across which fluids and dissolved substances (electrolytes, urea, glucose, albumin, osmotically active particles, and other small molecules) are exchanged from the blood. Fluid is introduced through a permanent tube in the abdomen and flushed out either every night while the patient sleeps (automatic peritoneal dialysis) or via regular exchanges throughout the day (continuous ambulatory peritoneal dialysis). PD is used as an alternative to hemodialysis though it is far less commonly used in many countries, such as the United States. It has comparable risks but is significantly less costly in most parts of the world, with the primary advantage being the ability to undertake treatment without visiting a medical facility. The primary complication of PD is infection due to the presence of a permanent tube in the abdomen.
We researched this topic for you and found the following best online resources. They are categorized into basic, advanced, and research level based on the extent of information you need. You will be taken to the respective websites by pressing on the links below.
https://www.hindawi.com/journals/bmri/2015/929806/ melisa lopez-anton, timothy bowen, and robert h. jenkins, “microrna regulation of peritoneal cavity homeostasis in peritoneal dialysis,” biomed research international, vol. 2015, article id 929806, 9 pages, 2015. doi:10.1155/2015/929806
kechrid mc, malik gh, shaikh jf, al-mohaya s, al-wakeel js, el gamal h. acute hydrothorax complicating continuous ambulatory peritoneal dialysis: a case report and review of literature. saudi j kidney dis transpl [serial online] 1999 [cited 2016 oct 17];10:163-6. available from: http://www.sjkdt.org/text.asp?1999/10/2/163/37224
https://www.hindawi.com/journals/ijn/2011/526753/ c. kennedy, c. mccarthy, s. alken, et al., “pleuroperitoneal leak complicating peritoneal dialysis: a case series,” international journal of nephrology, vol. 2011, article id 526753, 4 pages, 2011. doi:10.4061/2011/526753
https://www.hindawi.com/journals/crin/2014/323757/ anwar hamade, agnieszka pozdzik, o. denis, et al., “mycobacterium fortuitum and polymicrobial peritoneal dialysis-related peritonitis: a case report and review of the literature,” case reports in nephrology, vol. 2014, article id 323757, 5 pages, 2014. doi:10.1155/2014/323757
https://www.hindawi.com/journals/ijn/2011/198045/ angela yee-moon wang, “vascular and valvular calcification in chronic peritoneal dialysis patients,”international journal of nephrology, vol. 2011, article id 198045, 9 pages, 2011. doi:10.4061/2011/198045
https://www.hindawi.com/journals/ijn/2012/812609/ yeoungjee cho, sunil v. badve, carmel m. hawley, kathryn wiggins, and david w. johnson, “biocompatible peritoneal dialysis fluids: clinical outcomes,” international journal of nephrology, vol. 2012, article id 812609, 9 pages, 2012. doi:10.1155/2012/812609
https://www.hindawi.com/journals/bmri/2015/134708/ janusz witowski, edyta kawka, andras rudolf, and achim jörres, “new developments in peritoneal fibroblast biology: implications for inflammation and fibrosis in peritoneal dialysis,” biomed research international, vol. 2015, article id 134708, 7 pages, 2015. doi:10.1155/2015/134708